(Q38068065)

28 August 2017

2 references

23 October 2022

Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy (English)

1 reference

28 August 2017

Maryna C Eichelberger

series ordinal

2

object named as

Maryna C Eichelberger

1 reference

28 August 2017

Judy A Beeler

1

1 reference

28 August 2017

13 December 2012

1 reference

PubMed ID

23247146

28 August 2017

1 February 2013

1 reference

23 October 2022

Microbial Pathogenesis

2 references

28 August 2017

23 October 2022

55

1 reference

28 August 2017

9-15

1 reference

Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus

28 August 2017

1 reference

12 December 2020

Changing levels of measles antibody titers in women and children in the United States: impact on response to vaccination. Kaiser Permanente Measles Vaccine Trial Team

1 reference

12 December 2020

Regulation of T cell responses in the developing human fetus

1 reference

12 December 2020

The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

1 reference

12 December 2020

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

1 reference

12 December 2020

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

1 reference

12 December 2020

Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden

1 reference

12 December 2020

Neonatal administration of IL-12 enhances the protective efficacy of antiviral vaccines

1 reference

12 December 2020

Increased genetic and phenotypic stability of a promising live-attenuated respiratory syncytial virus vaccine candidate by reverse genetics

1 reference

12 December 2020

The underrecognized burden of influenza in young children.

1 reference

12 December 2020

Oil-in-water emulsion adjuvant with influenza vaccine in young children

1 reference

12 December 2020

Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

12 December 2020

Risk factors for severe respiratory syncytial virus infection among Alaska native children

1 reference

12 December 2020

Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children

1 reference

12 December 2020

Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children

1 reference

12 December 2020

The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines

1 reference

12 December 2020

Effect of maternal antibodies on the infant immune response

1 reference

12 December 2020

Phenotype and function of neonatal DC.

1 reference

12 December 2020

Influenza and the rates of hospitalization for respiratory disease among infants and young children

1 reference

12 December 2020

Functional crosstalk between dendritic cells and Foxp3(+) regulatory T cells in the maintenance of immune tolerance

1 reference

12 December 2020

Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis

1 reference

12 December 2020

AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland

1 reference

12 December 2020

Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants

1 reference

12 December 2020

Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China

1 reference

12 December 2020

The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise

1 reference

12 December 2020

Neonatal dendritic cells are intrinsically biased against Th-1 immune responses

1 reference

12 December 2020

Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics.

1 reference

12 December 2020

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

1 reference

12 December 2020

Unpredictable patterns of viral respiratory disease in children.

1 reference

12 December 2020

Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees.

1 reference

12 December 2020

T regulatory cells contribute to the attenuated primary CD8+ and CD4+ T cell responses to herpes simplex virus type 2 in neonatal mice

1 reference

12 December 2020

Influenza Immunization in Pregnancy — Antibody Responses in Mothers and Infants

1 reference

12 December 2020

Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

1 reference

12 December 2020

HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children

1 reference

12 December 2020

Placental and breast transfer of antibodies after maternal immunization with polysaccharide meningococcal vaccine: a randomized, controlled evaluation

1 reference

12 December 2020

Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women

1 reference

12 December 2020

Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies

1 reference

12 December 2020

Maternal antibody and respiratory syncytial virus infection in infancy

1 reference

12 December 2020

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

12 December 2020

The role of nasal IgA in children vaccinated with live attenuated influenza vaccine

1 reference

12 December 2020

Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus

1 reference

12 December 2020

Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study

1 reference

12 December 2020

Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children

1 reference

12 December 2020

Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months

1 reference

12 December 2020

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

1 reference

12 December 2020

Localized mucosal response to intranasal live attenuated influenza vaccine in adults

1 reference

12 December 2020

Safety and immunogenicity of trivalent inactivated influenza vaccine in infants

1 reference

12 December 2020

Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine

1 reference

12 December 2020

Pandemic influenza A H1N1 2009 infection versus vaccination: a cohort study comparing immune responses in pregnancy

1 reference

12 December 2020

Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis

1 reference

12 December 2020

The two amino acid substitutions in the L protein of cpts530/1009, a live-attenuated respiratory syncytial virus candidate vaccine, are independent temperature-sensitive and attenuation mutations

1 reference

12 December 2020

Live attenuated influenza vaccine provides superior protection from heterologous infection in pigs with maternal antibodies without inducing vaccine-associated enhanced respiratory disease

1 reference

12 December 2020

Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants

1 reference

12 December 2020

Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells

1 reference

12 December 2020

The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

1 reference

12 December 2020

Effectiveness of maternal influenza immunization in mothers and infants

1 reference

12 December 2020

The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.

1 reference

12 December 2020

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

1 reference

12 December 2020

Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group

1 reference

12 December 2020

Febrile seizures after 2010-2011 influenza vaccine in young children, United States: a vaccine safety signal from the vaccine adverse event reporting system

1 reference

12 December 2020

Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1.

1 reference

12 December 2020

Challenges in infant immunity: implications for responses to infection and vaccines

1 reference

12 December 2020

The burden of respiratory syncytial virus infection in young children

1 reference

12 December 2020

The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies

1 reference

12 December 2020

Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination.

1 reference

12 December 2020

Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

1 reference

12 December 2020

Twenty years of outpatient respiratory syncytial virus infection: a framework for vaccine efficacy trials

1 reference

12 December 2020

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group

1 reference

12 December 2020

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

1 reference

12 December 2020

The use of correlates of immunity in European Union licensing of influenza vaccines.

1 reference

12 December 2020

Neonatal adaptive immunity comes of age

1 reference

12 December 2020

Innate immunity of the newborn: basic mechanisms and clinical correlates

1 reference

12 December 2020

Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model

1 reference

12 December 2020

New insights for development of a safe and protective RSV vaccine

1 reference

12 December 2020

Maternal influenza vaccination and effect on influenza virus infection in young infants

1 reference

12 December 2020

Transplacental antibody transfer following maternal immunization with a pandemic 2009 influenza A(H1N1) MF59-adjuvanted vaccine.

1 reference

12 December 2020

Trends in vaccine adjuvants.

1 reference

12 December 2020

Swedish Medical Products Agency publishes report from a case inventory study on Pandemrix vaccination and development of narcolepsy with cataplexy.

1 reference

12 December 2020

Progress in respiratory virus vaccine development

1 reference

12 December 2020

Respiratory syncytial virus--United States, July 2007-June 2011.

1 reference

12 December 2020

Assessment of squalene adjuvanted and non-adjuvanted vaccines against pandemic H1N1 influenza in children 6 months to 17 years of age

1 reference

12 December 2020

Viral etiology of bronchiolitis among pediatric inpatients in northern Taiwan with emphasis on newly identified respiratory viruses

1 reference

12 December 2020

10.1016/J.MICPATH.2012.11.013

Identifiers

DOI

1 reference

28 August 2017

0 references

1 reference

PubMed ID

23247146